Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Innovage Holding Corp.
INNV
NASDAQ·Healthcare·Medical - Care Facilities·Mkt cap $1.6B
$11.99
▲ +2.39%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$3.13 - $12.64
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 182.2% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Integrated PACE model reducing fragmented care and hospitalizations
- Established network of 18 operational centers with 6,850+ participants
- Stable Medicare and Medicaid reimbursement structure
- Proven outcomes in senior health management and cost containment
- Multi-state geographic diversification across five states
Bear Case
2 risks
- Low volatility (beta 0.5).
- Premium valuation to Healthcare Facilities peers
Growth
Turning profitable
Aging U.S. population with growing demand for senior care services
Value
Premium valuation to Healthcare Facilities peers
Momentum
Hot
+53.9% over 3m
Quality
Stable
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying INNV right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: May 4, 2026
MAY 5, 2026
Reported EPS of -$0.22 vs $0.06 consensus (-466.7% surprise). Revenue of $251.9M vs $234.3M expected (+7.5%).
EPS surprise · last 4Q
0 of 1 beats
Q2 26
-466.7%
Next: May 4, 2026
Revenue trend · last 8Q
—
—
—
+11%
+13%
+9%
+6%
+15%
Q3 24
Q4 24
Q1 24
Q2 24
Q3 25
Q4 25
Q1 25
Q2 25
$193.1M
$199.4M
$205.1M
$209.0M
$218.1M
$218.1M
$236.1M
$239.7M
Margins · last 8Q
Gross
20.0%
Operating
6.7%
Profit
4.4%
Wall Street consensus
1 analyst · 0% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
0%
Hold
0%
Sell
100%
Median Price Target
—
Latest: JP Morgan · Feb 23, 2026